0 CHECKOUT

PRODUCT FILTERS

REGION

CATEGORIES

  • 1
  • 1
  • 1
  • 1

PRICE

0
0
0
3

PUBLISHED

2
3
3
3

PRODUCT TYPE

Search for: "Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Peptides"

Biomarkers - Technologies, Markets and Companies

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological...

Published:  August 2016
Price:  From

Cyclin-Dependent Kinase 5 (Serine/Threonine-Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or EC 2.7.11.22) - Pipeline Review, H1 2016

Cyclin-Dependent Kinase 5 (Serine/Threonine-Protein Kinase PSSALRE or Tau Protein Kinase II Catalytic Subunit or EC 2.7.11.22) - Pipeline Review, H1 2016 Summary ‘Cyclin-Dependent Kinase 5 (Serine/Threonine-Protein...

Published:  June 2016
Price:  From

Personalized Medicine - Scientific and Commercial Aspects

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her...

Published:  August 2016
Price:  From
Loading Indicator

Our Clients

  • Procter & Gamble Co.
  • Western Union Company
  • Volvo Car Corporation
  • Morgan Stanley
  • SAP SE
  • LG Corporation
  • Roche Diagnostics Ltd.